Grünkreis Pharma GmbH & Co. KG
Grünkreis Pharma GmbH & Co. KG is a registered legal entity registered in Germany under HRA 3950 FL Flensburg, and its current status with Handelsregister (Commercial Register) is active. The company was incorporated on 5 August 2005 and lists its registered address as Flensburg, Germany. 1 shareholder is on record for Grünkreis Pharma GmbH & Co. KG, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 15 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for Grünkreis Pharma GmbH & Co. KG, which has no share capital divided into shares.
The largest of these is Queisser Pharma GmbH & Co. KG, holding 100% — a majority holding.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Queisser Pharma GmbH & Co. KG | 100% | Handelsregister (Commercial Register) |
Officers
4
Two of the 4 officer records shown for Grünkreis Pharma GmbH & Co. KG are current appointments, filed with Handelsregister (Commercial Register). Ebba Loeck (appointed 2005-08-05) and Ralph Behrens (appointed 2005-08-05) both serve as Officer. The remaining 1 record shown (Bernd Hildebrandt) is a former appointment that has since been resigned.
Management authority at Grünkreis Pharma GmbH & Co. KG sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Grünkreis Pharma GmbH & Co. KG sits 1 level below its ultimate parent, HGDF Familienholding SE & Co. KG, registered in Germany. The full chain up to HGDF Familienholding SE & Co. KG is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Grünkreis Pharma GmbH & Co. KG's own shareholder record.
HGDF Familienholding SE & Co. KG
Germany
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Grünkreis Pharma GmbH & Co. KG?
One shareholder is currently on record for Grünkreis Pharma GmbH & Co. KG, which has no share capital divided into shares. The largest of these is Queisser Pharma GmbH & Co. KG, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Grünkreis Pharma GmbH & Co. KG's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Grünkreis Pharma GmbH & Co. KG is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Grünkreis Pharma GmbH & Co. KG have on record?
1 shareholder is shown on record for Grünkreis Pharma GmbH & Co. KG.
What is Grünkreis Pharma GmbH & Co. KG's company registration number?
Grünkreis Pharma GmbH & Co. KG's registration number is HRA 3950 FL Flensburg, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is Grünkreis Pharma GmbH & Co. KG still an active company?
Grünkreis Pharma GmbH & Co. KG's status on Handelsregister (Commercial Register) is listed as active.
When was Grünkreis Pharma GmbH & Co. KG incorporated?
Grünkreis Pharma GmbH & Co. KG was incorporated on 5 August 2005, according to Handelsregister (Commercial Register).
What is Grünkreis Pharma GmbH & Co. KG's registered address?
The registered address on file for Grünkreis Pharma GmbH & Co. KG is Flensburg, Germany.
Who are the officers/directors of Grünkreis Pharma GmbH & Co. KG?
Two of the 4 officer records shown for Grünkreis Pharma GmbH & Co. KG are current appointments, filed with Handelsregister (Commercial Register). Ebba Loeck (appointed 2005-08-05) and Ralph Behrens (appointed 2005-08-05) both serve as Officer. The remaining 1 record shown (Bernd Hildebrandt) is a former appointment that has since been resigned. Management authority at Grünkreis Pharma GmbH & Co. KG sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Grünkreis Pharma GmbH & Co. KG have a parent company or subsidiaries?
Grünkreis Pharma GmbH & Co. KG sits 1 level below its ultimate parent, HGDF Familienholding SE & Co. KG, registered in Germany.
Can Zavia monitor changes to Grünkreis Pharma GmbH & Co. KG's ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to Grünkreis Pharma GmbH & Co. KG's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Grünkreis Pharma GmbH & Co. KG's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like Grünkreis Pharma GmbH & Co. KG's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 15 October 2026.